Follow
Angelina R. Sekirnik
Angelina R. Sekirnik
Research Director, Comet Therapeutics
Verified email at vectivbio.com
Title
Cited by
Cited by
Year
Small molecule inhibitors of bromodomain–acetyl-lysine interactions
M Brand, AM Measures, BG Wilson, WA Cortopassi, R Alexander, ...
ACS chemical biology 10 (1), 22-39, 2014
1632014
Chemical epigenetics: the Impact of chemical and chemical biology techniques on bromodomain target validation
M Schiedel, M Moroglu, DMH Ascough, AER Chamberlain, JJAG Kamps, ...
Angewandte Chemie International Edition 58 (50), 17930-17952, 2019
292019
Isoxazole‐Derived Amino Acids are Bromodomain‐Binding Acetyl‐Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3
AR Sekirnik, DS Hewings, NH Theodoulou, L Jursins, KR Lewendon, ...
Angewandte Chemie International Edition 55 (29), 8353-8357, 2016
272016
Structure–activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1
JE Egleton, CC Thinnes, PT Seden, N Laurieri, SP Lee, KS Hadavizadeh, ...
Bioorganic & medicinal chemistry 22 (11), 3030-3054, 2014
272014
Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands
LE Jennings, AR Measures, BG Wilson, SJ Conway
Future medicinal chemistry 6 (2), 179-204, 2014
192014
Chemische Epigenetik: der Einfluss chemischer und chemo‐biologischer Techniken auf die Zielstruktur‐Validierung von Bromodomänen
M Schiedel, M Moroglu, DMH Ascough, AER Chamberlain, JJAG Kamps, ...
Angewandte Chemie 131 (50), 18096-18120, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–6